Congenital agenesis of the scrotum is a rare genetic/congenital condition where scrotal skin does not form. People with congenital agenesis of the scrotum may have undescended testes and differences in the appearance of the external genital area. It is present at birth and does not resolve, but features and needs can vary. Treatment focuses on surgical reconstruction and bringing any undescended testes into the scrotum to protect fertility and hormone function. The outlook depends on associated differences, and many children do well with coordinated urology and surgical care.
Overview
Congenital agenesis of the scrotumSymptoms
Congenital agenesis of the scrotum presents at birth with a missing or very underdeveloped scrotal sac and an atypical appearance of the external genital area. Testes may be undescended. Related differences of the penis, urethra, or groin structures can occur.
Outlook and prognosis
Most babies with congenital agenesis of the scrotum grow and develop well, especially with early urologic care. Testes are usually present but may be undescended; timely surgery supports fertility potential and hormone health. Regular follow-up helps monitor puberty, appearance, and psychosocial wellbeing.
Causes and risk factors
Congenital agenesis of the scrotum arises in early fetal development when the labioscrotal folds fail to form or fuse. Most cases are sporadic; no consistent pregnancy exposures. It may occur with differences in sex development, chromosomal abnormalities, or genetic syndromes.
Genetic influences
Genetics likely plays a central role in congenital agenesis of the scrotum, though confirmed causes are rare. Variations affecting early genital development pathways can contribute, sometimes alongside chromosomal differences. Family history is uncommon; most cases appear sporadic.
Diagnosis
Congenital agenesis of the scrotum is diagnosed by clinical features at birth, including absent scrotal tissue. Doctors confirm the diagnosis of congenital agenesis of the scrotum with imaging, genetic tests, and evaluation for associated anomalies.
Treatment and drugs
Treatment for congenital agenesis of the scrotum is highly personalized and usually planned by a pediatric urologist and plastic surgeon. Care may include creating or reshaping a scrotum with reconstructive surgery and positioning the testes, with hormone support if needed. Ongoing follow-up tracks growth, fertility potential, and wellbeing.
Symptoms
Right after birth, the area under the penis may look flat and smooth rather than forming a pouch. Early on, this might look like a missing scrotal sac or testicles not sitting where you’d expect. These are early features of congenital agenesis of the scrotum. Some babies also have related differences in the penis, urine stream, or groin that a newborn exam can pick up.
The skin under the penis does not form a pouch, so there are no scrotal folds. This visible difference is the hallmark of congenital agenesis of the scrotum.
One or both testicles may not be felt in the groin or under the penis because there is no scrotal sac. In congenital agenesis of the scrotum, the testes can lie higher in the groin or abdomen.
The pee opening may be lower on the penis (hypospadias), so the stream can spray, curve, or point downward. Caregivers may notice wet spots on the front of diapers or clothing.
The penis may sit closer to the lower abdomen or look smaller than expected, and the midline seam on the skin may be absent. These differences can affect how the area looks but not always how it works.
How people usually first notice Congenital agenesis of the scrotum?
Parents and clinicians usually notice the first signs of congenital agenesis of the scrotum at birth, when the scrotal skin is absent and the area looks smooth or atypical, sometimes with one or both testes not felt in the scrotal region. Newborn exams often prompt an urgent check for undescended testes, differences in the appearance of the external genitalia, and other associated differences that can occur with this condition. In some cases, prenatal ultrasound may hint at atypical external genital development, but most families first learn about it in the delivery room during the initial physical exam, reflecting how congenital agenesis of the scrotum is first noticed.
Types of Congenital agenesis of the scrotum
Congenital agenesis of the scrotum is a rare genetic/congenital condition where scrotal skin doesn’t form as expected, which can affect how the external genitals look and function. Variants are generally defined by how much scrotal tissue is missing and whether nearby structures, like the penis or testes, are also affected. People may notice different sets of symptoms depending on their situation. When reading about types of congenital agenesis of the scrotum, you’ll often see differences tied to whether the scrotum is completely absent or only partly formed, and whether the testes are in the scrotal position or located higher up.
Complete agenesis
The scrotum is entirely absent on both sides. The testes may be undescended or located in the groin, which can affect temperature regulation and fertility later. Urination and sexual function depend on the development of other structures.
Partial agenesis
Some scrotal tissue is present but underdeveloped or incomplete. One side may look more typical than the other, and the raphe or midline seam may be missing or displaced. Types of congenital agenesis of the scrotum often use this term when at least some scrotal skin is present.
Unilateral absence
One side of the scrotum is absent while the other side is formed. The present side may appear enlarged or stretched if it holds both testes. This can lead to asymmetry that becomes more noticeable with growth.
Peno‑scrotal fusion defects
The border between the penis and scrotum is unclear or fused, making the scrotum look shortened or displaced. The penis may appear tethered or partly hidden by adjacent skin. Surgeons may classify this as a variant when scrotal skin exists but is malpositioned.
Associated anomalies
Agenesis occurs alongside differences like hypospadias, undescended testes, or perineal anomalies. Symptoms reflect the combination, such as a urinary stream from a lower opening or absent scrotal sac with high‑riding testes. Not everyone will experience every type.
What genetics can tell you about symptoms
Some boys with certain HOXA13 or HOXD13 gene changes are born without a scrotum or with underdeveloped scrotal skin, because these genes guide genital shaping before birth. Variants in WT1 or AR, which influence testicular and male trait development, can add hypospadias, undescended testes, or ambiguous genital features.
Causes and risk factors
The root cause is a developmental change before birth that stops the scrotal skin from forming. It may happen alone or with other differences in sex development or nearby structures. In congenital agenesis of the scrotum, changes in genes or chromosomes that affect male sex hormones can be involved, but many cases have no clear cause. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Known risk factors for congenital agenesis of the scrotum are limited, but family history, close parental relatedness, and harmful exposures or illness during pregnancy may raise the chance.
Environmental and biological risk factors
Congenital agenesis of the scrotum is a rare difference that starts early in pregnancy, during the weeks when the external genitals are forming. Doctors often group risks into internal (biological) and external (environmental). Below are environmental and biological risk factors for congenital agenesis of the scrotum based on what is known about male genital development.
When the fetus does not receive or respond to enough male hormone signals during the early weeks when the scrotum would form, development may not proceed as expected. Reduced hormone action or blocked effects can raise the chance of congenital agenesis of the scrotum.
The placenta helps cue the fetus to make hormones needed for male genital formation. Problems that limit these signals may increase the risk of congenital agenesis of the scrotum.
Slower growth in the womb can reflect a strained placental and hormone environment. This pattern has been linked with differences in male genital development and may raise risk for this condition.
Diabetes present before pregnancy, especially if not well controlled, is linked with higher rates of birth differences. It has been associated with genitourinary anomalies and may contribute to this condition.
Genetic risk factors
Understanding the genetic causes of congenital agenesis of the scrotum can help families plan testing and care. In many cases, no single genetic change is found, but variants that affect androgen signaling and early genital formation can increase the chance of this rare finding. Some risk factors are inherited through our genes. Genetic testing may be considered when features suggest a known gene pathway is involved.
Androgen receptor variants: Changes in the androgen receptor (AR) gene can reduce how the body responds to androgens, the hormones that shape male genital development. This can lead to less masculinized genital development, sometimes including absent or minimal scrotal tissue. Patterns vary with how strongly the receptor is affected.
5-alpha-reductase deficiency: Variants in the SRD5A2 gene lower levels of DHT, a potent form of testosterone needed for scrotal formation. Reduced DHT can prevent the folds of tissue from fusing into a scrotum, contributing to congenital agenesis of the scrotum. Severity ranges widely between families.
Gonadal development genes: Changes in genes that guide early testes development, such as NR5A1 or WT1, can interfere with the signals needed for external genital formation. In some children, this results in atypical genital features that may include a missing scrotum. Genetic findings often come alongside other reproductive differences.
Sex chromosome differences: Differences in sex chromosomes, including mosaic patterns, can alter hormone production or response during fetal development. This can impair scrotal formation and lead to congenital agenesis of the scrotum or very limited scrotal tissue. Effects often vary even within the same chromosomal diagnosis.
Syndromic genetic conditions: Certain rare genetic syndromes that affect multiple organs can include abnormalities of the external genitalia. In these cases, scrotal agenesis may appear with other features, such as differences in limb or facial development. A genetics team can look for these patterns.
Inheritance patterns: Depending on the gene, inheritance may be X-linked (as with AR) or autosomal recessive (as with SRD5A2). These patterns influence recurrence risk in families and who may be affected. Genetic counseling can help clarify risks for future pregnancies.
Sporadic or de novo: Many reported cases of congenital agenesis of the scrotum are sporadic, with no identifiable genetic change found on standard testing. This suggests the chance of recurrence in siblings may be low, though not zero. More advanced testing may be discussed if clinical clues point to a genetic pathway.
Lifestyle risk factors
Lifestyle habits do not cause this condition, but they can shape day-to-day comfort, protect testicular health if testes are present, and reduce complications. Thinking about how lifestyle affects Congenital agenesis of the scrotum can help tailor choices that support fertility potential, skin health, and safety. The points below connect specific habits to practical effects on this anatomy. Your surgical plan and medical team’s guidance should anchor these choices.
Prolonged hot tubs, saunas, heated seats, or tight warming layers can raise groin temperature when scrotal cooling is absent, potentially lowering sperm quality. Choose breathable fabrics and limit sustained heat to protect any present testicular tissue.
Well-fitted, breathable supportive underwear can stabilize ectopic or surgically positioned testes and reduce torsion risk. Avoid overly tight compression that traps heat or causes pressure points.
Contact and straddle sports increase trauma risk to exposed or relocated testes. Use a properly fitted athletic cup and follow activity restrictions your surgeon recommends.
Long-duration cycling or horseback riding adds perineal pressure and heat that may irritate the area and affect comfort. Limit sessions, use padded seats, and alternate with low-impact activities.
Risk prevention
Congenital agenesis of the scrotum is present from birth, so preventing the condition itself usually isn’t possible. Prevention focuses on a healthy pregnancy, early recognition, and timely care to protect testicular health, fertility, and well‑being over time. Different people need different prevention strategies—there’s no single formula. Early, coordinated care can also lower the chance of complications and support development.
If there’s a family history or a previous child with related differences, meeting a genetic counselor can clarify recurrence risks. They can discuss options like carrier testing or prenatal diagnosis.
Early and regular antenatal visits support a healthy pregnancy and allow detailed ultrasound reviews. When differences are suspected, referral to fetal medicine can help plan delivery and newborn care.
During pregnancy, review all medicines and supplements with a clinician to avoid harmful drugs. Avoid alcohol, tobacco, and non-prescribed substances, and ask about workplace or household chemical exposures.
A careful newborn exam helps identify early symptoms of congenital agenesis of the scrotum and check whether the testes are descended. Prompt referral to pediatric urology and endocrinology can prevent delays in care.
Transmission
Congenital agenesis of the scrotum is present at birth and is not infectious—it cannot be caught, passed through contact, or spread in the community. In most cases, the cause is unknown and the condition occurs sporadically, with no family history. Occasionally, it can be part of a broader genetic syndrome that affects development of the external genitals; in those situations, how Congenital agenesis of the scrotum is inherited depends on the specific underlying condition. A genetics consultation can help estimate the chance of recurrence in future pregnancies, which is generally low when no syndrome or chromosomal change is found.
When to test your genes
Consider genetic testing if a baby is born without a scrotum or with atypical genital development, especially when undescended testes or differences in sex development are suspected. Testing is also reasonable with a family history of similar findings or known syndromes, or when doctors need results to guide surgery or hormone care. Early evaluation helps tailor treatment and coordinate specialists.
Diagnosis
At birth, many families and care teams first notice that the skin sac that usually holds the testes is missing, which can be alarming but is something doctors can evaluate promptly. Doctors usually begin with a careful physical exam and a review of pregnancy and family history. The genetic diagnosis of congenital agenesis of the scrotum often blends what is seen on exam with targeted tests to confirm the cause and plan care. Sometimes the next steps unfold in stages, with each test adding a piece of the picture.
A clinician looks closely at the external genitals to confirm the scrotal skin is absent rather than small or split. They also check where the testes are, how the penis looks, and whether the opening for urine is in the usual place.
A detailed family and prenatal history helps identify patterns that can run in families or point to related conditions. This information guides which tests are most useful.
Blood tests check hormone levels that reflect testicular development and function. Results can suggest whether testes are present and how well they are working.
Chromosome analysis and gene panels can look for changes linked to differences in genital development. Findings can confirm the diagnosis and inform counseling for the family.
Stages of Congenital agenesis of the scrotum
Congenital agenesis of the scrotum does not have defined progression stages. It is a structural difference present at birth, so it doesn’t typically worsen over time; diagnosis is usually made at delivery rather than based on early symptoms of congenital agenesis of the scrotum. Different tests may be suggested to help check for associated differences, such as an ultrasound of the pelvis, chromosome testing, and hormone levels. Care teams often also look for conditions that can occur alongside it and plan reconstructive options and follow-up as the child grows.
Outlook and prognosis
Daily routines often adapt as families learn what matters most: safe urination, comfort, and plans for future reconstruction. Congenital agenesis of the scrotum is rare, and the long-term outlook depends on which features occur alongside it, such as undescended testes, differences in genital development, or other birth differences. The outlook is not the same for everyone, but many children do well with coordinated care from urology, endocrinology, and pediatric surgery. Fertility prospects mainly hinge on testicular health and position; if testes are present and brought into the groin or scrotal area early, sperm-producing potential may be better protected. When early symptoms of congenital agenesis of the scrotum include undescended testes, timely surgery can reduce risks such as twisting of the testis or lower fertility later on.
Looking at the long-term picture can be helpful. Most people with congenital agenesis of the scrotum have a normal life expectancy, since the condition itself does not typically affect vital organs. Quality of life often improves after staged reconstruction that creates a scrotal pouch and positions the testes for protection and comfort. Some people notice changes in body image or confidence during adolescence, while for others, counseling and peer support programs make that transition easier. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, including the presence of a known genetic syndrome, timing of surgery, and routine follow-up.
Even though it can feel overwhelming, thoughtful planning usually leads to steady progress. Complications are more likely when testes remain undescended, when there are hormone differences, or when other organ systems are involved; your team will screen for these and address them early. Life-threatening issues are uncommon and usually relate to associated syndromes rather than the scrotal agenesis itself. Talk with your doctor about what your personal outlook might look like, including fertility counseling, surgical timing, and what to expect during puberty and adulthood.
Long-term effects
Congenital agenesis of the scrotum can have lifelong effects that depend on how the testes developed and where they sit. Long-term effects vary widely, and everyone’s path looks different, and ongoing support can help. Some people have typical hormone levels and sexual development, while others have differences that affect puberty, fertility, or urinary flow. Early care teams often focus on the best way to support healthy growth, function, and appearance over time.
When one or both testes are undescended, heat around the abdomen can affect how sperm develop later on. This also raises the lifetime risk of testicular cancer compared with descended testes.
Many with normally developed, descended testes have typical fertility. If the testes are undescended or underdeveloped, fertility may be reduced, and outcomes differ from person to person.
If the testes make enough testosterone, puberty and body changes usually progress as expected. If hormone production is lower, pubertal development may be slower or different.
Associated differences like hypospadias can affect urinary stream and, later, sexual function. With typical penile structure and a urethral opening at the tip, day‑to‑day function is often unaffected.
How is it to live with Congenital agenesis of the scrotum?
Daily life with congenital agenesis of the scrotum can involve practical challenges around genital support, urination, and comfort in clothing, along with decisions about reconstructive surgery and ongoing urologic or endocrine care. Many live well with tailored medical plans, but body image, intimacy, and questions about fertility or gender expression can bring emotional weight that benefits from sensitive counseling and peer support. Families and partners often play a key role—learning the medical basics, using affirming language, and showing patience during appointments and recovery can make everyday routines and social situations feel safer and more manageable. Over time, most people find a workable rhythm, combining medical follow-up with small adjustments—like supportive garments and clear communication—to build confidence at school, work, and in relationships.
Treatment and drugs
Treatment for congenital agenesis of the scrotum focuses on creating a functional, natural-looking scrotum and addressing any related genital or urinary differences that may occur alongside the condition. Care is usually managed by a pediatric urologist and a plastic or reconstructive surgeon; surgery is often planned in stages, timed to the child’s growth, with options like tissue expansion or grafts to form a scrotal sac and, when needed, procedures to position the testes in the new scrotum. Doctors sometimes recommend a combination of lifestyle changes and drugs if there is associated pain, infection risk, or skin care needs after surgery, though medicines play a smaller role than surgery in this condition. As your child grows, follow-up checks help monitor testicular health, fertility potential later in life, and the cosmetic result, with revisions offered if needed. It’s natural to have questions about congenital agenesis of the scrotum, so ask your doctor about the best starting point for you.
Non-drug treatment
Care for congenital agenesis of the scrotum focuses on protecting urinary and sexual function, supporting body image, and planning safe reconstruction as a child grows. Because early symptoms of congenital agenesis of the scrotum are usually noticed at birth, teams often begin planning in infancy and adjust over time. Non-drug treatments often lay the foundation for surgery, recovery, and long-term follow-up. Plans vary based on whether the testes, urethra, or other structures are also affected.
Surgeons can create or expand scrotal tissue to improve protection of the testes and appearance. Timing is individualized, often in early childhood, with revisions possible as a child grows. Techniques aim to preserve sensation and blood flow.
If a testis has not descended, orchiopexy can move it into the new scrotum. This helps protect fertility potential and allows easier exams. It can also lower the risk of testicular twisting.
Hormone testing checks typical male hormone levels and guides timing of procedures. Results can inform whether hormonal therapy is needed around surgery. Follow-up testing tracks changes through puberty.
Families can review possible genetic causes and what they may mean for future pregnancies. Counselors explain testing options and help interpret results in plain language. Written summaries support shared decision-making.
Your genes may have an impact on how drugs work for you
Genes can change how your body processes pain medicines, antibiotics, or anesthesia often used around surgeries for congenital agenesis of the scrotum, affecting dose, timing, and side effects. Pharmacogenetic testing can guide safer choices, especially for anesthesia and opioid sensitivity.
Pharmacological treatments
Medicines play a supporting role in congenital agenesis of the scrotum, mainly around hormone support and surgery. Drugs are used to help with related needs such as micropenis, undescended testes, pain control, and infection prevention. There are no early symptoms of congenital agenesis of the scrotum that medicines directly treat. Not everyone responds to the same medication in the same way.
Testosterone enanthate or cypionate injections may be used to support penile growth in infancy or to induce puberty if testes make too little hormone. Dosing may be increased or lowered gradually to balance benefits and side effects.
Topical DHT gel can be considered in select infants with micropenis, especially when a 5‑alpha–reductase issue is suspected. Care is needed to avoid skin-to-skin transfer to caregivers or siblings.
Human chorionic gonadotropin may be used short term to stimulate the testes to produce testosterone in infancy or early childhood. Benefits vary, and monitoring for fluid retention or early pubic hair is important.
Medicines such as buserelin or triptorelin are sometimes tried for undescended testes in some regions. Evidence for lasting benefit is limited, and surgery remains the usual approach.
Genetic influences
Genetic factors can influence how the external genitals form in the womb. In congenital agenesis of the scrotum, most cases seem to happen as a one‑time developmental event and are not clearly inherited. Family history is one of the strongest clues to a genetic influence. In some children, the condition occurs as part of a broader genetic syndrome or a difference in sex development linked to changes in chromosomes, specific genes, or the way hormone signals are received. Doctors may consider genetic counseling and testing to look for genetic causes of congenital agenesis of the scrotum, especially when other birth differences or a suggestive family history are present. Even when a gene change is found, its effects can vary within a family, and not everyone with the change will have the same findings.
Is Congenital agenesis of the scrotum genetic?
Genetics likely plays a central role in congenital agenesis of the scrotum, though confirmed causes are rare. Variations affecting early genital development pathways can contribute, sometimes alongside chromosomal differences. Family history is uncommon; most cases appear sporadic.
Pharmacogenetics—how genetics influence drug effects
Treatment for congenital agenesis of the scrotum usually centers on surgery and, in some cases, short-term hormone therapy. Genes can shape both choices. For example, in babies with differences in sex development, certain gene results can predict whether testosterone is likely to help, or whether a dihydrotestosterone (DHT)–based approach—or no androgen at all—makes more sense. Alongside medical history and surgical planning, genetic testing for congenital agenesis of the scrotum can help tailor anesthesia, pain control, and hormone use.
Pharmacogenetics also matters around the operating room. A family tendency to severe fevers and muscle stiffness with anesthesia (malignant hyperthermia) can be genetic, so the anesthetic team may avoid triggering drugs and choose safer alternatives. Differences in how the liver processes pain medicines can affect dosing; children who convert codeine too quickly are at risk, so many teams avoid codeine and tramadol altogether and use other options. If testing shows conditions such as G6PD deficiency, certain antibiotics are avoided during recovery.
Interactions with other conditions
For many families, other health issues travel alongside congenital agenesis of the scrotum, shaping both care plans and the timing of surgery. It often occurs with genital differences like hypospadias and undescended testes, and sometimes with inguinal hernias or penoscrotal transposition. Some conditions share “underlying mechanisms,” such as hormone-related differences in sex development that affect how the external genitals form before birth. Kidney and urinary tract differences may also be checked, since nearby structures can develop together early in pregnancy. When undescended testes are present, the risks tied to that condition—like lower fertility later on and a slightly higher chance of testicular cancer—are addressed using standard care pathways. Early signs of congenital agenesis of the scrotum are apparent at birth, so teams can coordinate evaluations across urology, endocrinology, and genetics if needed. Emotional and body-image support matters too, especially when another condition affects genital appearance or function. Ask your care team how findings from one condition may influence the timing or choice of procedures for another.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies born with differences in the external genitals, sometimes noting a smooth area where a scrotum would usually form. Early midwives and physicians recorded these findings in birth notes and case books, often focusing on how the child urinated and whether both testicles could be felt. Families might recall a grandfather’s story of “undescended testes” without realizing the skin itself had developed differently. These community memories show how rare findings were noticed long before modern terms existed.
First described in the medical literature as a distinctive lack of scrotal skin, congenital agenesis of the scrotum was initially grouped together with other genital differences because doctors mainly had symptoms and appearance to go by. As hospital records grew in the 19th and early 20th centuries, single case reports began to separate “absent scrotum” from conditions with a small or split scrotum. Authors often sketched the anatomy, commented on associated findings like hypospadias or undescended testes, and debated whether the difference was isolated or part of a wider pattern of development.
Over time, descriptions became clearer. Surgeons compared how the labioscrotal folds—the skin that usually forms the scrotum—had changed direction or failed to fuse. Pediatric specialists added information about hormone levels and testis position, while pathologists outlined how nearby structures developed. With this, congenital agenesis of the scrotum moved from a vague label to a defined feature with its own criteria.
In recent decades, knowledge has built on a long tradition of observation. Ultrasound and later fetal imaging allowed clinicians to suspect genital differences before birth, and newborn exams documented features in a more standardized way. Reports noted that congenital agenesis of the scrotum can appear alone or alongside other differences in sex development, and that the day-to-day impact ranges widely depending on testis position, urinary function, and future fertility considerations.
Advances in genetics helped explain why the skin may not form a scrotum in some pregnancies. Researchers linked certain gene changes and chromosome differences to patterns where scrotal skin does not develop as expected. Not every case has a clear genetic cause, and for many, no specific change is found, but these studies shifted thinking from “rare curiosity” to a developmental pathway we can study and sometimes predict.
Despite evolving definitions, the goal has stayed constant: to understand the child in front of the clinician and to guide families through choices about evaluation, timing of any surgery, and long-term care. Knowing the condition’s history helps explain why older terms vary and why modern teams use careful, neutral language. Today’s approach builds on centuries of observation, combining physical exam, imaging, and genetic insights to give clearer answers than were possible in earlier eras.